2 Neuroscience2.11 Integrated neurobiology of syndromes and states

2.11.10 Neurocognitive deficits in psychotic disorders

2 min read1 figure

Written by Resident Doctor Committee · Published

Affected domains

Cognition in schizophrenia averages 1 to 1.5 standard deviations below controls, with wide variation between people.

Domain

Impairment

Processing speed

Large deficit on timed tasks

Attention

Poor sustained attention, variable responses

Working memory

Verbal and visuospatial

Learning and episodic memory

Poor encoding and retrieval

Executive function

Planning, flexibility, abstraction, inhibition

Social cognition

Emotion recognition, mentalising; independently affects outcome

  • Recognition exceeds free recall, which points to a retrieval problem, unlike the poor recognition and marked forgetting of hippocampal amnesia.

Trait and endophenotype evidence

  • Cognitive differences precede psychosis, persist between episodes and appear in milder form in unaffected relatives.

  • This makes cognition a candidate endophenotype, though the findings overlap with bipolar disorder.

Course and function

  • Childhood differences are mild, ultra high-risk people show intermediate impairment, and cognition often falls further around the first episode.

  • Cognition is then usually stable: progressive, dementia-like decline is not the usual course.

  • Cognition predicts work, independence and social function better than positive symptoms do, which supports cognitive remediation and vocational support.

Circuits

System

Finding

Correlate

Dorsolateral prefrontal cortex

Inefficient activation under load

Working memory, executive control

Hippocampus

Weak prefrontal coupling

Episodic memory

Cortico-cerebellar-thalamo-cortical circuit

Cognitive dysmetria (Andreasen)

Timing of mental activity

White matter

Reduced fractional anisotropy

Processing speed

  • Prefrontal inefficiency describes the finding better than universal hypofrontality.

Neurochemical models

Model

Evidence

Limitation

Dopamine D1 hypofunction

Working memory follows an inverted U with prefrontal dopamine

No proven D1 treatment

N-methyl-D-aspartate (NMDA) receptor hypofunction

Ketamine; NMDA receptor encephalitis

Glutamatergic drugs lack reliable benefit

Gamma-aminobutyric acid (GABA) interneurone dysfunction

Reduced glutamic acid decarboxylase (GAD67), altered parvalbumin interneurones

May be secondary to NMDA hypofunction

Synaptic pruning

Fewer cortical spines, complement gene findings

Confounded by illness and treatment

Electrophysiology

Measure

Finding in psychosis

Mismatch negativity

Reduced amplitude

P300

Lower amplitude, delayed latency

Gamma synchrony

Reduced, including 40 Hz auditory response

P50 sensory gating

Reduced suppression to paired clicks

The red difference wave, deviant response minus standard response, is the mismatch negativity (negative is plotted upward), and its amplitude is reduced in psychosis. Alex Brandmeyer, Makiko Sadakata, Loukianos Spyrou, James M. McQueen and Peter Desain, CC BY 4.0, via Wikimedia Commons
  • Relatives also show smooth pursuit and antisaccade abnormalities, but overlap with healthy values means no measure diagnoses an individual.

Reversible contributors

  • Symptoms, mood, poor sleep, substances and physical illness (obesity, diabetes, hypertension, sleep apnoea, smoking, thyroid disease) all lower scores.

  • Sedation, extrapyramidal effects and anticholinergic burden worsen cognition, so review procyclidine, high doses and polypharmacy.

  • Test after acute symptoms settle, and interpret scores against education, language and premorbid ability.

Psychosis, delirium and dementia

Feature

Psychosis

Delirium

Dementia

Onset

May predate psychosis

Hours to days

Months to years

Course

Relatively stable

Fluctuating

Progressive

Consciousness

Clear

Altered

Clear early

Memory

Retrieval difficulty

Poor registration

Poor encoding in Alzheimer disease

Orientation

Preserved

Often impaired

Declines

Hallucinations

Often auditory

Often visual

Visual in Lewy body disease

  • Investigate new decline for delirium, medication, substances, physical illness and dementia rather than putting it down to schizophrenia.